InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
64,401.91
(
0.36%
)
Post# of 29332
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

N33

Send PM Follow Ignore
Followers 16
Posts 337
Boards Moderated 0
Alias Born 03/21/2014

N33

Re: None

Tuesday, 05/20/2014 5:03:02 PM

Tuesday, May 20, 2014 5:03:02 PM

Post# of 29332
The Company is attempting to develop and grow its intellectual property and product portfolio, incorporating key cannabinoid-based products, which management believes will substantially enhance shareholder value. Our scientific team has gained significant and exciting evidence from our initial research which we expect will assist us in the development of a new generation of botanically derived anti-inflammatory and pain management products with broad applications.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up